Shots:

• AstraZeneca has signed an agreement with EU’s IVA- spearheaded by Germany- France- Italy- and the Netherlands- to supply up to 400M doses of the University of Oxford’s AZD1222- with deliveries starting by the end of 2020
• The collaboration allows IVA to accelerate the supply of the vaccine and to provide equitable access to all participating countries across the EU
• Additionally- AstraZeneca had signed a similar kind of agreement with US- UK- CEPI- GAVI for $700M doses- and collaborated with SII for 1B doses. Last month- Oxford University has initiated P- II/III UK trial of AZD1222 in ~10-000 adult volunteers

Click here to read full press release/ article 

Ref: AstraZeneca | Image: Barrons